148 related articles for article (PubMed ID: 23110613)
1. Nordic walking decreased circulating chemerin and leptin concentrations in middle-aged men with impaired glucose regulation.
Venojärvi M; Wasenius N; Manderoos S; Heinonen OJ; Hernelahti M; Lindholm H; Surakka J; Lindström J; Aunola S; Atalay M; Eriksson JG
Ann Med; 2013 Mar; 45(2):162-70. PubMed ID: 23110613
[TBL] [Abstract][Full Text] [Related]
2. 12 weeks' aerobic and resistance training without dietary intervention did not influence oxidative stress but aerobic training decreased atherogenic index in middle-aged men with impaired glucose regulation.
Venojärvi M; Korkmaz A; Wasenius N; Manderoos S; Heinonen OJ; Lindholm H; Aunola S; Eriksson JG; Atalay M
Food Chem Toxicol; 2013 Nov; 61():127-35. PubMed ID: 23623841
[TBL] [Abstract][Full Text] [Related]
3. Plasma irisin is increased following 12 weeks of Nordic walking and associates with glucose homoeostasis in overweight/obese men with impaired glucose regulation.
Korkmaz A; Venojärvi M; Wasenius N; Manderoos S; Deruisseau KC; Gidlund EK; Heinonen OJ; Lindholm H; Aunola S; Eriksson JG; Atalay M
Eur J Sport Sci; 2019 Mar; 19(2):258-266. PubMed ID: 30132382
[TBL] [Abstract][Full Text] [Related]
4. Link between chemerin, central obesity, and parameters of the Metabolic Syndrome: findings from a longitudinal study in obese children participating in a lifestyle intervention.
Niklowitz P; Rothermel J; Lass N; Barth A; Reinehr T
Int J Obes (Lond); 2018 Oct; 42(10):1743-1752. PubMed ID: 30030480
[TBL] [Abstract][Full Text] [Related]
5. Effects of weight loss and exercise on chemerin serum concentrations and adipose tissue expression in human obesity.
Chakaroun R; Raschpichler M; Klöting N; Oberbach A; Flehmig G; Kern M; Schön MR; Shang E; Lohmann T; Dreßler M; Fasshauer M; Stumvoll M; Blüher M
Metabolism; 2012 May; 61(5):706-14. PubMed ID: 22136911
[TBL] [Abstract][Full Text] [Related]
6. Are serum chemerin levels different between obese and non-obese polycystic ovary syndrome women?
Yang S; Wang Q; Huang W; Song Y; Feng G; Zhou L; Tan J
Gynecol Endocrinol; 2016; 32(1):38-41. PubMed ID: 26291816
[TBL] [Abstract][Full Text] [Related]
7. Effects of rhythmic aerobic exercise plus core stability training on serum omentin, chemerin and vaspin levels and insulin resistance of overweight women.
Faramarzi M; Banitalebi E; Nori S; Farzin S; Taghavian Z
J Sports Med Phys Fitness; 2016 Apr; 56(4):476-82. PubMed ID: 25651894
[TBL] [Abstract][Full Text] [Related]
8. Serum concentrations of adipokines in men with prostate cancer and benign prostate hyperplasia.
Siemińska L; Borowski A; Marek B; Nowak M; Kajdaniuk D; Warakomski J; Kos-Kudła B
Endokrynol Pol; 2018; 69(2):120-127. PubMed ID: 29465157
[TBL] [Abstract][Full Text] [Related]
9. Circulating chemerin decreases in response to a combined strength and endurance training.
Stefanov T; Blüher M; Vekova A; Bonova I; Tzvetkov S; Kurktschiev D; Temelkova-Kurktschiev T
Endocrine; 2014 Apr; 45(3):382-91. PubMed ID: 23783366
[TBL] [Abstract][Full Text] [Related]
10. Decrease in serum chemerin through aerobic exercise plus dieting and its association with mitigation of cardio-metabolic risk in obese female adolescents.
Liu M; Lin X; Wang X
J Pediatr Endocrinol Metab; 2018 Jan; 31(2):127-135. PubMed ID: 29306931
[TBL] [Abstract][Full Text] [Related]
11. Effect of lifestyle modification on serum chemerin concentration and its association with insulin sensitivity in overweight and obese adults with type 2 diabetes.
Kim SH; Lee SH; Ahn KY; Lee DH; Suh YJ; Cho SG; Choi YJ; Lee DH; Lee SY; Hong SB; Kim YS; Jeon JY; Nam M
Clin Endocrinol (Oxf); 2014 Jun; 80(6):825-33. PubMed ID: 23682797
[TBL] [Abstract][Full Text] [Related]
12. The increase of serum chemerin concentration is mainly associated with the increase of body mass index in obese, non-diabetic subjects.
Sledzinski T; Korczynska J; Hallmann A; Kaska L; Proczko-Markuszewska M; Stefaniak T; Sledzinski M; Swierczynski J
J Endocrinol Invest; 2013 Jun; 36(6):428-34. PubMed ID: 23211604
[TBL] [Abstract][Full Text] [Related]
13. Chemerin as a marker of body fat and insulin resistance in women with polycystic ovary syndrome.
Kort DH; Kostolias A; Sullivan C; Lobo RA
Gynecol Endocrinol; 2015 Feb; 31(2):152-5. PubMed ID: 25295622
[TBL] [Abstract][Full Text] [Related]
14. Elevated chemerin levels in Pakistani men: an interrelation with metabolic syndrome phenotypes.
Fatima SS; Bozaoglu K; Rehman R; Alam F; Memon AS
PLoS One; 2013; 8(2):e57113. PubMed ID: 23468920
[TBL] [Abstract][Full Text] [Related]
15. Chemerin is associated with metabolic syndrome phenotypes in a Mexican-American population.
Bozaoglu K; Segal D; Shields KA; Cummings N; Curran JE; Comuzzie AG; Mahaney MC; Rainwater DL; VandeBerg JL; MacCluer JW; Collier G; Blangero J; Walder K; Jowett JB
J Clin Endocrinol Metab; 2009 Aug; 94(8):3085-8. PubMed ID: 19470637
[TBL] [Abstract][Full Text] [Related]
16. Chemerin is a novel adipokine associated with obesity and metabolic syndrome.
Bozaoglu K; Bolton K; McMillan J; Zimmet P; Jowett J; Collier G; Walder K; Segal D
Endocrinology; 2007 Oct; 148(10):4687-94. PubMed ID: 17640997
[TBL] [Abstract][Full Text] [Related]
17. Associations Between Plasma Chemerin Concentrations and Bone Quality in Adults From the General Population.
Kadric L; Zylla S; Nauck M; Völzke H; Friedrich N; Hannemann A
Endocrinology; 2018 Jun; 159(6):2378-2385. PubMed ID: 29701774
[TBL] [Abstract][Full Text] [Related]
18. Association between serum chemerin concentrations and clinical indices in obesity or metabolic syndrome: a meta-analysis.
Li Y; Shi B; Li S
PLoS One; 2014; 9(12):e113915. PubMed ID: 25469985
[TBL] [Abstract][Full Text] [Related]
19. Effect of diet and diet combined with chronic aerobic exercise on chemerin plasma concentrations and adipose tissue in obese women.
Lakhdar N; Landolsi M; Bouhlel E; Tabka Z
Neuro Endocrinol Lett; 2019 Dec; 40(6):262-270. PubMed ID: 32200585
[TBL] [Abstract][Full Text] [Related]
20. Relationship of serum novel adipokine chemerin levels with body composition, insulin resistance, dyslipidemia and diabesity in Saudi women.
Habib SS; Eshki A; AlTassan B; Fatani D; Helmi H; AlSaif S
Eur Rev Med Pharmacol Sci; 2017 Mar; 21(6):1296-1302. PubMed ID: 28387898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
